Phase I trial of remimazolam to assess the abuse potential
Phase of Trial: Phase I
Latest Information Update: 09 Aug 2017
At a glance
- Drugs Remimazolam (Primary)
- Indications Sedation
- Focus Adverse reactions
- 09 Aug 2017 According to a PAION media release, part 1 with twelve subject successfully completed.
- 09 Aug 2017 According to a PAION media release, before conducting this study, interations with FDA are planned in fourth quarter 2017.
- 23 Mar 2017 Company is planning multiple Phase I studies to assess the abuse potential of remimazolam, for now created only one profile. But may need to create more profiles based on more specific info. about two aspcts of the trial/s.